Patients Patient adherence – the key to restoring trust in pharma Medication is a staple of modern medicine, with almost 50% of adults in the United Sta
R&D Novartis’ Kesimpta, ECTRIMS 2022, and relapsing multiple scl... Having presented new data at last year’s European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Annual Meeting – where the safety and efficacy of Novartis’ Kesimpta (
Sales & Marketing Why script-to-dispense conversion will take centre stage in ... With the US economy teetering on a recession, sales and marketing budgets are expected to take a hit among businesses across sectors.
Views & Analysis The power of self-management to target gaps in chronic disea... The time of healthcare professionals is limited, but systems often rely on them as the principal means to help patients with chronic diseases.
News Novartis pulls plug on landmark UK cholesterol trial ORION-17 study has been abandoned, with Novartis opting instead for a smaller global trial.
R&D Sponsored An inside guide to unlocking clinical research in the UK An inside guide to unlocking clinical research in the UK
